North American Cancer Biomarker Market Trends, Size, Competitive Analysis and Forecast 2019-2025
North American cancer biomarker market is growing at a CAGR of around 11.8% during the forecast period. The North American market for cancer biomarker is a significant market and is analysed on the basis of country as the US and Canada. Factors that are contributing significantly in the market growth includes research and development, and high healthcare expenditure and so on. Moreover, rising number of cancer patients are considered to be one of the major factors that are driving the growth of North American cancer biomarker market.
To Request a Sample of our Report on North American Cancer Biomarker Market: https://www.omrglobal.com/request-sample/north-american-cancer-biomarker-market
Accordingly, the expenditure rate of the US is more than that of Canada
as the US government invests more on research and development and there is more
business opportunity in the US as compared to Canada. The major factors that
are driving the North American cancer biomarker market includes rising
healthcare spending, R&D investments, high quality of healthcare
infrastructure and demand for personalized medicine in the region. The change
in lifestyle is also a major factor that increases the possibilities of cancer
in North America such as inadequate diet, consumption of alcohol and smoking.
For example, as per the Chief Public Health Officer’s (CPHO) Report 2015, an
estimated 22 million Canadians representing almost 80% of the population
consumed alcohol in 2013. About 4.4 million Canadians consumed alcohol that
could lead to many fatal diseases, such as various forms of cancer.
The rising healthcare expenditure can have an important role in the
development of the cancer-based therapies and personalized drugs. Moreover,
according to the National Cancer Institute in 2017, estimated national
expenditures for cancer care in the US was $147.3 billion. In the future, this
cost is expected to increase with the aging population coupled with increasing
cancer prevalence. It is also expected to increase with the adoption of new and
often more expensive treatments as standards of care, thus contributing towards
the growth of the North American cancer biomarker market growth.
A
full Report of North American Cancer Biomarker Market is Available
at: https://www.omrglobal.com/industry-reports/north-american-cancer-biomarker-market
North American Cancer Biomarker Market Segmentation
·
Genetic
Biomarker
·
Protein
Biomarker
By Cancer
Type
·
Lung
Cancer
·
Prostate
Cancer
·
Breast
Cancer
·
Colorectal
Cancer
·
Cervical
Cancer
·
Other
By
Applications
·
Drug
Discovery and Development
·
Diagnosis
·
Risk
Assessment
·
Prognostics
By Profiling
Technology
·
Omics
Technology
·
Immunoassays
·
Cytogenetics
·
Bioinformatics
Regional
Analysis
North America
·
United States
·
Canada
Company Profiles
·
Abbott
laboratories Inc.
·
Astellas
Pharma Inc.
·
Becton,
Dickson and Co.
·
Bio-Rad
Laboratories, Inc.
·
Danaher
Corp.
·
F.
Hoffmann-La Roche Ltd.
·
Merck
and Co., Inc.
·
Novartis
AG
·
Pfizer
Inc.
·
QIAGEN
GmbH
·
Thermo
Fisher Scientific Inc
Reasons to Buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/north-american-cancer-biomarker-market
About Orion Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment